Home>Mutual Funds>Nippon India Mutual Fund>Nippon India Pharma Fund Growth
shareSHARE

Nippon India Pharma Fund Growth-0.72%

51.84%
1 Year Return
Equity
Sectoral/Thematic
5.0star
6M
1Y
3Y
5Y
All

Fund Details

Nippon India Pharma Fund Growth

RiskVery High
Min SIP Amount₹100
Expense Ratio1.97%
NAV₹261.15 (13 Apr 2021)
Fund Started05 Jun 2004
Fund Size4,261 Cr

Returns

1Y
3Y*
5Y*
Since inception*
Fund Returns
51.8%
23.5%
14.4%
18.6%
Category Average
49.8%
20.9%
10.7%
-
Rank Within Category
4
1
1
-
*All returns are annualized.
SIP
ONE TIME
Minimum SIP amount100
Amount Per Month₹5,000
Duration
1Y back
3Y back
5Y back
Would have become
0
with 51.8% returns per annum

Comparison

Data not available
Pros
1. Age is more than 10 years
2. 1Y Returns are higher than the category average returns
3. 3Y Returns are higher than the category average returns
4. 5Y Returns are higher than the category average returns
5. 10Y Returns are higher than the category average returns
Cons
1. Higher expense ratio - 1.99%

Top Holdings

NameSectorInstrument% Assets
Sun Pharmaceutical Inds. Ltd.HealthcareEquity11.2%
Aurobindo Pharma Ltd.HealthcareEquity9.9%
Dr. Reddy's Laboratories Ltd.HealthcareEquity9.8%
Cipla Ltd.HealthcareEquity9.8%
Lupin Ltd.HealthcareEquity9.6%
Divi's Laboratories Ltd.HealthcareEquity8.9%
Fortis Healthcare Ltd.HealthcareEquity7.3%
Gland Pharma Ltd.HealthcareEquity6.4%
Cadila Healthcare Ltd.HealthcareEquity5.6%
Thyrocare Technologies Ltd.HealthcareEquity3.9%
See All

Fund Managers

Sailesh Raj Bhan
keyboard_arrow_down

Nippon India Pharma Fund Growth Details

Nippon India Pharma Fund Growth is a Equity Mutual Fund Scheme launched by Nippon India Mutual Fund. This scheme was made available to investors on 05 Jun 2004. Sailesh Raj Bhan is the Current Fund Manager of Nippon India Pharma Fund Growth fund.The fund currently has an Asset Under Management(AUM) of ₹4,261 Cr and the Latest NAV as of 13 Apr 2021 is ₹261.15.

The Nippon India Pharma Fund Growth is rated Very High risk. Minimum SIP Investment is set to 100. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 1 month.

Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Tax Implications

Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.

Scheme Information Document(SID)

₹5000
Min for First Investment
₹1000
Min for Second Investment
Exit load of 1% if redeemed within 1 month.
Exit Load

Compare Funds

Nippon India Pharma Fund Growth
VS
search

About Nippon India Mutual Fund

Address
Corporate Office : Reliance Centre, 7th Floor South Wing, OFf Western Express Highway, Santacruz(E) Mumbai-400055
Phone
022-33031000/30301111
Launch Date
30 Jun 1995
Nippon India Mutual Fund
Asset Management Company
Custodian
Deutsche Bank
Registrar & Transfer Agent
KFin Tech
Address
Karvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,
Loading...
Similar Funds
ⓒ 2016-2021 Groww. All rights reserved, Built with in India